- VC-style research lens applied to public markets
- Inception: 06/30/2005
- Rebalance: Quarterly
- Approx. turnover: ~15–20% (approx.)
- Calculated by: Refinitiv (LSEG)
ER30TR — Entrepreneur 30 Total Return Index
A venture-capital lens for public markets — built on 20+ years of research.
Powered by a proprietary Entrepreneur Factor® framework evaluating companies across 18 proprietary attributes.
Incorporating venture-capital principles into public-market investing.
- Proprietary, rules-based methodology
- 18-attribute Entrepreneur Factor® model (entrepreneurship + innovation characteristics)
- Disciplined maintenance with scheduled rebalances (quarterly)
Index Details
| Type Index |
| Inception Date 06/30/2005 |
Index Strategy
ER30TR applies a venture-capital lens to public markets, built on 20+ years of research. The proprietary Entrepreneur Factor® framework evaluates companies across 18 proprietary attributes designed to surface entrepreneurial leadership and innovation characteristics. The index is rules-based and rebalanced quarterly to maintain disciplined exposure over time.
Index Performance (Growth of $10,000)
As of: 12/31/2025
Index Documents
| Index Performance Chart As of 12/31/2025 |
Fund Performance Graph
As of 12.31.2025
| NAV | $- |
| Market Price | $- |
Sector Allocations
| Information Technology 40.14% |
| Health Care 17.05% |
| Financials 14.77% |
| Communication Services 11.77% |
| Consumer Discretionary 5.82% |
| Consumer Staples 4.86% |
| Energy 3.03% |
| Industrials 2.55% |
As of 12.31.2025
Sector Allocations are subject to change
ERShares ER30TR Index Annualized Performance
* All performance figures shown are annualized.
The ERShares ER30TR Index selects the most entrepreneurial, primarily US Large Cap companies, that meet the threshold embedded in the proprietary Entrepreneur Factor® (EF). It is not possible to invest directly in the Index, and past performance does not guarantee future results. Investors should conduct their own research and consider the risks associated with any investments linked to the Index.
Access ER30TR Exposure
Investors can access strategies linked to the ER30TR Index through listed funds.
ER30TR Index Overview
The ER30TR — ERShares 30 Total Return Index is a proprietary, rules-based benchmark that applies a venture-capital lens to public markets. Built on 20+ years of research, the ER30TR methodology is powered by the Entrepreneur Factor®, a framework that evaluates companies across 18 proprietary attributes designed to surface entrepreneurial leadership and innovation characteristics. The index is designed for long-horizon benchmarking and is maintained through scheduled rebalances.
Why ER30TR
- Rules-based index methodology focused on entrepreneurial and innovation traits
- U.S. large-cap universe with a systematic, repeatable approach
- Entrepreneur Factor® framework using 18 proprietary attributes
- Quarterly rebalancing with approximately 15–20% turnover (approx.)
ER30TR Index FAQ
The ER30TR — ERShares 30 Total Return Index is a proprietary, rules-based benchmark that applies a venture-capital lens to public markets. Built on 20+ years of research, the ER30TR methodology is powered by the Entrepreneur Factor®, a framework that evaluates companies across 18 proprietary attributes designed to surface entrepreneurial leadership and innovation characteristics. The index is designed for long-horizon benchmarking and is maintained through scheduled rebalances.
The ER30TR Index is a proprietary, rules-based benchmark created by ERShares to evaluate U.S. large-cap companies using the Entrepreneur Factor® framework.
The methodology applies a systematic framework built on 20+ years of research and evaluates companies across 18 proprietary attributes. The index is maintained through scheduled rebalances.
The index is rebalanced quarterly and has approximately 15–20% turnover (approx.).
Disclosures
ER30TR Index Disclosure:
The ERShares ER30TR Index selects the most entrepreneurial, primarily US Large Cap companies, that meet the threshold embedded in the proprietary Entrepreneur Factor® (EF). It is not possible to invest directly in the Index, and past performance does not guarantee future results. Investors should conduct their own research and consider the risks associated with any investments linked to the Index.
